{"entities":{"Q9819":{"pageid":13980,"ns":120,"title":"Item:Q9819","lastrevid":205740,"modified":"2020-05-21T15:45:19Z","type":"item","id":"Q9819","labels":{"en":{"language":"en","value":"He SZ, et al. Leuk. Lymphoma (2015) cited as Ref 556 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9819$BA983CBD-719B-4F6D-9943-93882FBEB833","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9819$02129A43-5408-447B-9B7E-A8847FF6ABF8","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"He SZ","type":"string"},"datatype":"string"},"type":"statement","id":"Q9819$B466916D-370C-4F39-8EAC-8F6594BDA8B8","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.3109/10428194.2014.956316","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9819$CD7FDE48-21C2-4518-B0C4-737FCB69C396","rank":"normal"}],"P140":[{"mainsnak":{"snaktype":"value","property":"P140","datavalue":{"value":"25248882","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9819$4CB03576-62F8-43E1-81F8-AF38B4248AB7","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2015-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9819$A6EFC6F5-505D-4213-9C77-D17AE28A3E8B","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Leuk. Lymphoma","type":"string"},"datatype":"string"},"type":"statement","id":"Q9819$6C0E7074-6337-495A-A13F-44603A6F3D50","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"56","type":"string"},"datatype":"string"},"type":"statement","id":"Q9819$DAD35982-811C-4B03-853B-F65C7016E7EB","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"A phase 1 study of the safety pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed refractory or high-risk acute myeloid leukemia","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9819$0C80CEE3-D54C-4A57-AE46-14332B90CAF4","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"1406-1415","type":"string"},"datatype":"string"},"type":"statement","id":"Q9819$A29BEC68-0E91-416F-B96B-06583C3FA73F","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"He SZ, et al. Leuk. Lymphoma (2015) cited as Ref 556 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/He_SZ,_et_al._Leuk._Lymphoma_(2015)_cited_as_Ref_556_in_DOI:_10.1038/s41392-020-0110-5"}}}}}